Clinical Trial Update: 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients [Phase 4]

View source ↗

Summary

Phase 4 open-label, non-comparative switch study of ziprazidone in previously treated schizophrenia patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ziprazidone (Ziprazidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED